NDC 70720-101 – Varubi

Rolapitant Hydrochloride 90 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC70720-101

Product details

Brand name
Varubi
Generic name
Rolapitant
Labeler
TerSera Therapeutics LLC
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA206500
Marketed since
October 7, 2015
Listing expires
December 31, 2026
Pharmacologic class
Substance P/Neurokinin-1 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Varubi →

Package NDC codes (1)

Package NDCDescriptionSince
70720-101-022 TABLET in 1 BLISTER PACK (70720-101-02)Aug 6, 2019

Other Varubi products